Last 12 months
Inside the activity.
0 purchase rows · 42 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 10 |
| Jan 2026 | 0 | 17 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 13 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 11, 2018 Filed May 15, 2018 22:26 UTC |
Topper James NDirector
|
OtherCommon Stock | 301,024 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-18-000438 · edgar.xml · nonDerivative · entry 3 Topper James N · CIK 0001341382 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F3 · kind: Effective May 11, 2018, FHM V, L.P. distributed in-kind, without consideration, a total of 301,024 shares of Common Stock of the Issuer to its limited partners. F3 · ownership.nature: Effective May 11, 2018, FHM V, L.P. distributed in-kind, without consideration, a total of 301,024 shares of Common Stock of the Issuer to its limited partners. Read SEC document |
| May 11, 2018 Filed May 15, 2018 22:26 UTC |
Topper James NDirector
|
OtherCommon Stock | 301,024 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-18-000438 · edgar.xml · nonDerivative · entry 2 Topper James N · CIK 0001341382 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 301,024 F2 · kind: Shares acquired by FHM V, L.P. through a distribution in-kind from FH V. FHM V, L.L.C. is the general partner of FHM V, L.P. The reporting person disclaims beneficial ownership of all shares held by the foregoing entities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. F2 · ownership.nature: Shares acquired by FHM V, L.P. through a distribution in-kind from FH V. FHM V, L.L.C. is the general partner of FHM V, L.P. The reporting person disclaims beneficial ownership of all shares held by the foregoing entities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| May 11, 2018 Filed May 15, 2018 22:26 UTC |
Topper James NDirector
|
OtherCommon Stock | 1,372,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-18-000438 · edgar.xml · nonDerivative · entry 1 Topper James N · CIK 0001341382 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 973,612 F1 · kind: Effective May 11, 2018, Frazier Healthcare V, L.P. ("FH V"), distributed in-kind, without consideration, a total of 1,372,000 shares of Common Stock of the Issuer to its general and limited partners. The remaining securities are held by FH V. FHM V, L.L.C. is the general partner of FHM V, L.P. which is the general partner of FH V. The reporting person disclaims beneficial ownership of all shares held by the foregoing entities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. F1 · ownership.nature: Effective May 11, 2018, Frazier Healthcare V, L.P. ("FH V"), distributed in-kind, without consideration, a total of 1,372,000 shares of Common Stock of the Issuer to its general and limited partners. The remaining securities are held by FH V. FHM V, L.L.C. is the general partner of FHM V, L.P. which is the general partner of FH V. The reporting person disclaims beneficial ownership of all shares held by the foregoing entities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| April 16, 2018 Filed Apr 18, 2018 20:46 UTC |
Lydon NicholasDirector
|
SaleCommon Stock | 2,222 | $90.26 | $200,549.05 |
DisclosureSEC source: 0001209191-18-025382 · doc4.xml · nonDerivative · entry 7 Lydon Nicholas · CIK 0001639935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,106 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F9 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $89.93 to $90.69 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| April 16, 2018 Filed Apr 18, 2018 20:46 UTC |
Lydon NicholasDirector
|
SaleCommon Stock | 2,803 | $89.42 | $250,631.37 |
DisclosureSEC source: 0001209191-18-025382 · doc4.xml · nonDerivative · entry 6 Lydon Nicholas · CIK 0001639935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,328 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F8 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $88.91 to $89.87 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| April 16, 2018 Filed Apr 18, 2018 20:46 UTC |
Lydon NicholasDirector
|
SaleCommon Stock | 4,250 | $88.30 | $375,267.35 |
DisclosureSEC source: 0001209191-18-025382 · doc4.xml · nonDerivative · entry 5 Lydon Nicholas · CIK 0001639935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,131 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F7 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $87.91 to $88.90 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| April 16, 2018 Filed Apr 18, 2018 20:46 UTC |
Lydon NicholasDirector
|
SaleCommon Stock | 9,425 | $87.46 | $824,340.66 |
DisclosureSEC source: 0001209191-18-025382 · doc4.xml · nonDerivative · entry 4 Lydon Nicholas · CIK 0001639935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,381 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F6 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $86.91 to $87.895 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| April 16, 2018 Filed Apr 18, 2018 20:46 UTC |
Lydon NicholasDirector
|
SaleCommon Stock | 1,390 | $86.15 | $119,752.95 |
DisclosureSEC source: 0001209191-18-025382 · doc4.xml · nonDerivative · entry 3 Lydon Nicholas · CIK 0001639935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 289,806 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F5 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $85.75 to $86.73 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| April 16, 2018 Filed Apr 18, 2018 20:46 UTC |
Lydon NicholasDirector
|
SaleCommon Stock | 10,310 | $85.11 | $877,491.32 |
DisclosureSEC source: 0001209191-18-025382 · doc4.xml · nonDerivative · entry 2 Lydon Nicholas · CIK 0001639935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 291,196 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $84.75 to $85.74 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| April 16, 2018 Filed Apr 18, 2018 20:46 UTC |
Lydon NicholasDirector
|
SaleCommon Stock | 2,600 | $84.18 | $218,879.96 |
DisclosureSEC source: 0001209191-18-025382 · doc4.xml · nonDerivative · entry 1 Lydon Nicholas · CIK 0001639935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,506 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $83.69 to $84.64 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| March 05, 2018 Filed Mar 6, 2018 22:22 UTC |
FENTON DENNIS MDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,507 | $0.00 Strike: $118.97 | $0.00 |
DisclosureSEC source: 0001209191-18-017377 · doc4.xml · derivative · entry 2 FENTON DENNIS M · CIK 0001184627 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,507 Underlying: Common Stock · 5,507 shares Expires 2028-03-04 F2 · derivative.exercise_date: The stock option vests and becomes exercisable in 11 equal monthly installments beginning on April 2, 2018, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| March 05, 2018 Filed Mar 6, 2018 22:22 UTC |
FENTON DENNIS MDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $118.97 | $0.00 |
DisclosureSEC source: 0001209191-18-017377 · doc4.xml · derivative · entry 1 FENTON DENNIS M · CIK 0001184627 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires 2028-03-04 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 36 equal monthly installments beginning on April 5, 2018, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 21:08 UTC |
Lydon NicholasDirector
|
Exercise / conversionSeries C Preferred Stock Warrant (right to buy) · Derivative | 16,483 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001209191-18-011264 · doc4.xml · derivative · entry 2 Lydon Nicholas · CIK 0001639935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,843 shares Expires 2018-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Immediately prior to the closing of the Issuer's initial public offering, the warrant became exercisable for shares of common stock. F2 · derivative.exercise_date: This warrant is exercisable at any time. F1 · derivative.underlying: Immediately prior to the closing of the Issuer's initial public offering, the warrant became exercisable for shares of common stock. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 21:08 UTC |
Lydon NicholasDirector
|
Exercise / conversionCommon Stock | 16,483 | $4.55 | $74,997.65 |
DisclosureSEC source: 0001209191-18-011264 · doc4.xml · nonDerivative · entry 1 Lydon Nicholas · CIK 0001639935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,106 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Immediately prior to the closing of the Issuer's initial public offering, the warrant became exercisable for shares of common stock. Read SEC document |
| February 02, 2018 Filed Feb 6, 2018 21:22 UTC |
Ware J. AnthonyDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $104.81 | $0.00 |
DisclosureSEC source: 0001209191-18-007840 · doc4.xml · derivative · entry 1 Ware J. Anthony · CIK 0001715429 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires 2028-02-01 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 12 equal monthly installments beginning on March 2, 2018, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| February 02, 2018 Filed Feb 6, 2018 21:16 UTC |
Schmid John P.Director
|
GrantDirector Stock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $104.81 | $0.00 |
DisclosureSEC source: 0001209191-18-007834 · doc4.xml · derivative · entry 1 Schmid John P. · CIK 0001478916 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires 2028-02-01 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 12 equal monthly installments beginning on March 2, 2018, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| February 02, 2018 Filed Feb 6, 2018 21:18 UTC |
Schoeneck James ADirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $104.81 | $0.00 |
DisclosureSEC source: 0001209191-18-007835 · doc4.xml · derivative · entry 1 Schoeneck James A · CIK 0001420987 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires 2028-02-01 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 12 equal monthly installments beginning on March 2, 2018, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| February 02, 2018 Filed Feb 6, 2018 21:13 UTC |
RENTON HOLLINGSDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $104.81 | $0.00 |
DisclosureSEC source: 0001209191-18-007832 · doc4.xml · derivative · entry 1 RENTON HOLLINGS · CIK 0001187333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires 2028-02-01 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 12 equal monthly installments beginning on March 2, 2018, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| February 02, 2018 Filed Feb 6, 2018 21:09 UTC |
Gallagher Carol GiltnerDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $104.81 | $0.00 |
DisclosureSEC source: 0001209191-18-007828 · doc4.xml · derivative · entry 1 Gallagher Carol Giltner · CIK 0001329959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires 2028-02-01 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 12 equal monthly installments beginning on March 2, 2018, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| February 02, 2018 Filed Feb 6, 2018 21:20 UTC |
Topper James NDirector · 10% owner
|
GrantDirector Stock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $104.81 | $0.00 |
DisclosureSEC source: 0001209191-18-007838 · doc4.xml · derivative · entry 1 Topper James N · CIK 0001341382 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires 2028-02-01 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 12 equal monthly installments beginning on March 2, 2018, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| February 02, 2018 Filed Feb 6, 2018 21:11 UTC |
Lydon NicholasDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $104.81 | $0.00 |
DisclosureSEC source: 0001209191-18-007830 · doc4.xml · derivative · entry 1 Lydon Nicholas · CIK 0001639935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires 2028-02-01 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 12 equal monthly installments beginning on March 2, 2018, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| January 26, 2018 Filed Jan 30, 2018 21:16 UTC |
Piscitelli DominicChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 23,000 | $0.00 Strike: $106.84 | $0.00 |
DisclosureSEC source: 0001209191-18-006000 · doc4.xml · derivative · entry 1 Piscitelli Dominic · CIK 0001695028 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,000 Underlying: Common Stock · 23,000 shares Expires 2028-01-25 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the shares subject to the option on January 26, 2019, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Read SEC document |
| January 26, 2018 Filed Jan 30, 2018 21:13 UTC |
Londei MarcoChief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 28,000 | $0.00 Strike: $106.84 | $0.00 |
DisclosureSEC source: 0001209191-18-005997 · doc4.xml · derivative · entry 1 Londei Marco · CIK 0001654500 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 28,000 shares Expires 2028-01-25 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the shares subject to the option on January 26, 2019, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Read SEC document |
| January 26, 2018 Filed Jan 30, 2018 21:12 UTC |
Suria HamzaDirector · President, CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 63,000 | $0.00 Strike: $106.84 | $0.00 |
DisclosureSEC source: 0001209191-18-005995 · doc4.xml · derivative · entry 1 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,000 Underlying: Common Stock · 63,000 shares Expires 2028-01-25 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the shares subject to the option on January 26, 2019, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Read SEC document |
| August 22, 2017 Filed Aug 24, 2017 22:41 UTC |
Ware J. AnthonyDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 10,694 | $0.00 Strike: $21.45 | $0.00 |
DisclosureSEC source: 0001209191-17-050211 · doc4.xml · derivative · entry 2 Ware J. Anthony · CIK 0001715429 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,694 Underlying: Common Stock · 10,694 shares Expires 2027-08-21 F2 · derivative.exercise_date: The stock option vests and becomes fully exercisable on May 30, 2018. Read SEC document |
| August 22, 2017 Filed Aug 24, 2017 22:41 UTC |
Ware J. AnthonyDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 28,571 | $0.00 Strike: $21.45 | $0.00 |
DisclosureSEC source: 0001209191-17-050211 · doc4.xml · derivative · entry 1 Ware J. Anthony · CIK 0001715429 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,571 Underlying: Common Stock · 28,571 shares Expires 2027-08-21 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 36 equal monthly installments beginning on September 22, 2017, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| August 21, 2017 Filed Aug 21, 2017 21:11 UTC |
NOVO HOLDINGS A/S10% owner
|
SaleCommon Stock | 356,300 | $21.10 | $7,518,250.67 |
DisclosureSEC source: 0001209191-17-049733 · doc4.xml · nonDerivative · entry 1 Novo Holdings A/S · CIK 0001388325 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,936,604 F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.10 to $22.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 15, 2017 Filed Aug 16, 2017 20:56 UTC |
NOVO HOLDINGS A/S10% owner
|
SaleCommon Stock | 143,428 | $21.00 | $3,011,988.00 |
DisclosureSEC source: 0001209191-17-049237 · doc4.xml · nonDerivative · entry 2 Novo Holdings A/S · CIK 0001388325 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,292,904 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in two transactions with one transaction pricing at $21.00 and the other transaction pricing at $21.07. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price set forth in this footnote. Read SEC document |
| August 14, 2017 Filed Aug 16, 2017 20:56 UTC |
NOVO HOLDINGS A/S10% owner
|
SaleCommon Stock | 35,172 | $21.79 | $766,492.84 |
DisclosureSEC source: 0001209191-17-049237 · doc4.xml · nonDerivative · entry 1 Novo Holdings A/S · CIK 0001388325 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,436,332 F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.525 to $22.225, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 07, 2017 Filed Aug 8, 2017 22:08 UTC |
NOVO HOLDINGS A/S10% owner
|
SaleCommon Stock | 1,023 | $22.92 | $23,442.56 |
DisclosureSEC source: 0001209191-17-048152 · doc4.xml · nonDerivative · entry 3 Novo Holdings A/S · CIK 0001388325 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,471,504 F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.76 to $23.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 07, 2017 Filed Aug 8, 2017 22:08 UTC |
NOVO HOLDINGS A/S10% owner
|
SaleCommon Stock | 480,000 | $21.10 | $10,128,000.00 |
DisclosureSEC source: 0001209191-17-048152 · doc4.xml · nonDerivative · entry 2 Novo Holdings A/S · CIK 0001388325 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,472,527 Read SEC document |
| August 04, 2017 Filed Aug 8, 2017 22:08 UTC |
NOVO HOLDINGS A/S10% owner
|
SaleCommon Stock | 10,271 | $22.00 | $225,963.03 |
DisclosureSEC source: 0001209191-17-048152 · doc4.xml · nonDerivative · entry 1 Novo Holdings A/S · CIK 0001388325 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,952,527 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in two transactions with one transaction pricing at $22.00 and the other transaction pricing at $22.01. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price set forth in this footnote. Read SEC document |
| August 03, 2017 Filed Aug 3, 2017 21:21 UTC |
NOVO HOLDINGS A/S10% owner
|
SaleCommon Stock | 21,451 | $22.01 | $472,192.28 |
DisclosureSEC source: 0001209191-17-047444 · doc4.xml · nonDerivative · entry 3 Novo Holdings A/S · CIK 0001388325 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,962,798 F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.000 to $22.175, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 02, 2017 Filed Aug 3, 2017 21:21 UTC |
NOVO HOLDINGS A/S10% owner
|
SaleCommon Stock | 25,700 | $23.87 | $613,484.70 |
DisclosureSEC source: 0001209191-17-047444 · doc4.xml · nonDerivative · entry 2 Novo Holdings A/S · CIK 0001388325 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,984,249 F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.75 to $24.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 21:21 UTC |
NOVO HOLDINGS A/S10% owner
|
SaleCommon Stock | 23,555 | $23.87 | $562,269.63 |
DisclosureSEC source: 0001209191-17-047444 · doc4.xml · nonDerivative · entry 1 Novo Holdings A/S · CIK 0001388325 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,009,949 F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.80 to $24.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 26, 2017 Filed Jul 28, 2017 15:52 UTC |
Avalon Ventures VII L P10% owner
AVALON VENTURES VII GP, LLC10% owner · See Remarks
Kinsella Kevin J10% owner · See Remarks
Tomlin Stephen Lawrence10% owner · See Remarks
|
SaleCommon Stock | 37,040 | $24.35 | $901,924.00 |
DisclosureSEC source: 0000899243-17-019280 · doc4.xml · nonDerivative · entry 3 Avalon Ventures VII L P · CIK 0001318999 · 10% owner AVALON VENTURES VII GP, LLC · CIK 0001380392 · 10% owner · See Remarks Kinsella Kevin J · CIK 0001311643 · 10% owner · See Remarks Tomlin Stephen Lawrence · CIK 0001695652 · 10% owner · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F3 · kind: Represents the open-market sale by Avalon Ventures VII GP, LLC, the general partner of Avalon Ventures VII, L.P., of the Common Stock received as a result of the in-kind distribution described in footnote 1. F3 · ownership.nature: Represents the open-market sale by Avalon Ventures VII GP, LLC, the general partner of Avalon Ventures VII, L.P., of the Common Stock received as a result of the in-kind distribution described in footnote 1. Read SEC document |
| July 26, 2017 Filed Jul 28, 2017 15:52 UTC |
Avalon Ventures VII L P10% owner
AVALON VENTURES VII GP, LLC10% owner · See Remarks
Kinsella Kevin J10% owner · See Remarks
Tomlin Stephen Lawrence10% owner · See Remarks
|
OtherCommon Stock | 37,040 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-019280 · doc4.xml · nonDerivative · entry 2 Avalon Ventures VII L P · CIK 0001318999 · 10% owner AVALON VENTURES VII GP, LLC · CIK 0001380392 · 10% owner · See Remarks Kinsella Kevin J · CIK 0001311643 · 10% owner · See Remarks Tomlin Stephen Lawrence · CIK 0001695652 · 10% owner · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 37,040 F2 · kind: Represents the receipt by Avalon Ventures VII GP, LLC, the general partner of Avalon Ventures VII, L.P., of its pro-rata portion of the in-kind distribution described in footnote 1. F2 · ownership.nature: Represents the receipt by Avalon Ventures VII GP, LLC, the general partner of Avalon Ventures VII, L.P., of its pro-rata portion of the in-kind distribution described in footnote 1. Read SEC document |
| July 26, 2017 Filed Jul 28, 2017 15:52 UTC |
Avalon Ventures VII L P10% owner
AVALON VENTURES VII GP, LLC10% owner · See Remarks
Kinsella Kevin J10% owner · See Remarks
Tomlin Stephen Lawrence10% owner · See Remarks
|
OtherCommon Stock | 399,987 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-019280 · doc4.xml · nonDerivative · entry 1 Avalon Ventures VII L P · CIK 0001318999 · 10% owner AVALON VENTURES VII GP, LLC · CIK 0001380392 · 10% owner · See Remarks Kinsella Kevin J · CIK 0001311643 · 10% owner · See Remarks Tomlin Stephen Lawrence · CIK 0001695652 · 10% owner · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,636,945 F1 · kind: Represents a pro-rata in-kind distribution of Common Stock by Avalon Ventures VII, L.P. effected on July 26, 2017 without consideration to its limited partners and to its general partner, Avalon Ventures VII GP, LLC. F1 · ownership.nature: Represents a pro-rata in-kind distribution of Common Stock by Avalon Ventures VII, L.P. effected on July 26, 2017 without consideration to its limited partners and to its general partner, Avalon Ventures VII GP, LLC. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 23:44 UTC |
Piscitelli DominicChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $24.60 | $0.00 |
DisclosureSEC source: 0001209191-17-015447 · doc4.xml · derivative · entry 1 Piscitelli Dominic · CIK 0001695028 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2027-02-23 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the shares subject to the option on February 24, 2018, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 23:56 UTC |
Schmid John P.Director
|
GrantDirector Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $24.60 | $0.00 |
DisclosureSEC source: 0001209191-17-015462 · doc4.xml · derivative · entry 1 Schmid John P. · CIK 0001478916 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2017-02-23 F1 · derivative.exercise_date: The stock option vests and becomes fully exercisable on February 24, 2018. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 23:59 UTC |
Schoeneck James ADirector
|
GrantDirector Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $24.60 | $0.00 |
DisclosureSEC source: 0001209191-17-015465 · doc4.xml · derivative · entry 1 Schoeneck James A · CIK 0001420987 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-02-23 F1 · derivative.exercise_date: The stock option vests and becomes fully exercisable on February 24, 2018. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 23:55 UTC |
RENTON HOLLINGSDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $24.60 | $0.00 |
DisclosureSEC source: 0001209191-17-015461 · doc4.xml · derivative · entry 1 RENTON HOLLINGS · CIK 0001187333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-02-23 F1 · derivative.exercise_date: The stock option vests and becomes fully exercisable on February 24, 2018. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 23:46 UTC |
Topper James NDirector · 10% owner
|
GrantDirector Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $24.60 | $0.00 |
DisclosureSEC source: 0001209191-17-015450 · doc4.xml · derivative · entry 1 Topper James N · CIK 0001341382 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-02-23 F1 · derivative.exercise_date: The stock option vests and becomes fully exercisable on February 24, 2018. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 18:43 UTC |
MOYLE MATTHEWChief Scientific Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $24.60 | $0.00 |
DisclosureSEC source: 0001209191-17-015445 · doc4.xml · derivative · entry 1 MOYLE MATTHEW · CIK 0001218102 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2027-02-23 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the shares subject to the option on February 24, 2018, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 23:53 UTC |
Gallagher Carol GiltnerDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $24.60 | $0.00 |
DisclosureSEC source: 0001209191-17-015458 · doc4.xml · derivative · entry 1 Gallagher Carol Giltner · CIK 0001329959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-02-23 F1 · derivative.exercise_date: The stock option vests and becomes fully exercisable on February 24, 2018. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 23:54 UTC |
Lydon NicholasDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $24.60 | $0.00 |
DisclosureSEC source: 0001209191-17-015460 · doc4.xml · derivative · entry 1 Lydon Nicholas · CIK 0001639935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-02-23 F1 · derivative.exercise_date: The stock option vests and becomes fully exercisable on February 24, 2018. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 23:42 UTC |
Londei MarcoChief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 110,000 | $0.00 Strike: $24.60 | $0.00 |
DisclosureSEC source: 0001209191-17-015444 · doc4.xml · derivative · entry 1 Londei Marco · CIK 0001654500 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,000 Underlying: Common Stock · 110,000 shares Expires 2027-02-23 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the shares subject to the option on February 24, 2018, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 23:40 UTC |
Suria HamzaDirector · President, CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 225,000 | $0.00 Strike: $24.60 | $0.00 |
DisclosureSEC source: 0001209191-17-015443 · doc4.xml · derivative · entry 1 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,000 Underlying: Common Stock · 225,000 shares Expires 2027-02-23 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the shares subject to the option on February 24, 2018, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Read SEC document |
| February 02, 2017 Filed Feb 6, 2017 17:14 UTC |
Frazier Healthcare VII, L.P.10% owner
Frazier Healthcare VII-A, L.P.10% owner
FHM VII, L.P.10% owner
FHM VII, L.L.C.10% owner
FRAZIER ALAN D10% owner
Naini Nader J10% owner
Every Nathan R10% owner
Heron Patrick J10% owner
|
OtherWarrants · Derivative | 117,235 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001012975-17-000092 · edgar.xml · derivative · entry 2 Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner FHM VII, L.P. · CIK 0001654632 · 10% owner FHM VII, L.L.C. · CIK 0001654631 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 117,235 shares Expires 2018-11-04 F1 · derivative.exercise_date: This warrant is exercisable at any time. F2 · ownership.nature: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| February 02, 2017 Filed Feb 6, 2017 17:14 UTC |
Frazier Healthcare VII, L.P.10% owner
Frazier Healthcare VII-A, L.P.10% owner
FHM VII, L.P.10% owner
FHM VII, L.L.C.10% owner
FRAZIER ALAN D10% owner
Naini Nader J10% owner
Every Nathan R10% owner
Heron Patrick J10% owner
|
OtherCommon Stock | 117,235 | $4.55 | $533,419.25 |
DisclosureSEC source: 0001012975-17-000092 · edgar.xml · nonDerivative · entry 1 Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner FHM VII, L.P. · CIK 0001654632 · 10% owner FHM VII, L.L.C. · CIK 0001654631 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,345,612 F2 · ownership.nature: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.